United States · FDA National Drug Code directory
bivalirudin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0781-3158_6d393e10-b1f2-42b1-bc50-920309c144c6
- Product NDC
- 0781-3158
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- bivalirudin
- Labeler
- Sandoz Inc
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20150615
- Source listing expiry
- 20271231
Source-listed ingredients
- BIVALIRUDIN — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-USE in 1 CARTON (0781-3158-95) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (0781-3158-94) · 0781-3158-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →